Ronald Asbury Andrews is Director of Precipio, Inc.. Currently has a direct ownership of 11,128 shares of PRPO, which is worth approximately $70,106. The most recent transaction as insider was on Oct 15, 2024, when has been sold 1,510 shares (Common Stock) at a price of $6.62 per share, resulting in proceeds of $9,996. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.1K
15.7% 3M change
158.31% 12M change
Total Value Held $70,106

RONALD ASBURY ANDREWS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 15 2024
BUY
Grant, award, or other acquisition
$9,996 $6.62 p/Share
1,510 Added 11.95%
11,128 Common Stock
Jul 15 2024
BUY
Grant, award, or other acquisition
$9,986 $4.63 p/Share
2,157 Added 18.32%
9,618 Common Stock
Apr 15 2024
BUY
Grant, award, or other acquisition
$20,998 $6.66 p/Share
3,153 Added 29.71%
7,461 Common Stock
Oct 24 2023
BUY
Grant, award, or other acquisition
-
4,005 Added 48.18%
4,308 Common Stock
Sep 12 2023
BUY
Grant, award, or other acquisition
-
6,060 Added 50.0%
6,060 Common Stock

Also insider at

OCX
Oncocyte Corp Healthcare
RAA

Ronald Asbury Andrews

Director
Irvine, CA

Track Institutional and Insider Activities on PRPO

Follow Precipio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRPO shares.

Notify only if

Insider Trading

Get notified when an Precipio, Inc. insider buys or sells PRPO shares.

Notify only if

News

Receive news related to Precipio, Inc.

Track Activities on PRPO